Latest On China Medical System Holdings Limited (CHSYF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-08-30 06:07 EST | Dividend | A dividend of $0.16 has been announced on Aug 15, 2024. It will be paid Sep 9, 2024 with an ex-dividend date of Aug 30, 2024. | Neutral |  |
| 2024-05-15 06:05 EST | Dividend | A dividend of $0.09 has been announced on Mar 27, 2024. It will be paid May 23, 2024 with an ex-dividend date of May 15, 2024. | Neutral | |
| 2023-09-12 06:04 EST | Dividend | A dividend of $0.34 has been announced on Aug 28, 2023. It will be paid Sep 20, 2023 with an ex-dividend date of Sep 12, 2023. | Neutral | |
| 2023-05-04 06:04 EST | Dividend | A dividend of $0.27 has been announced on Mar 16, 2023. It will be paid May 12, 2023 with an ex-dividend date of May 4, 2023. | Neutral | |
| 2022-09-06 06:05 EST | Dividend | A dividend of $0.34 has been announced on Aug 22, 2022. It will be paid Sep 15, 2022 with an ex-dividend date of Sep 6, 2022. | Neutral | |
| 2022-04-27 06:04 EST | Dividend | A dividend of $0.28 has been announced on Mar 15, 2022. It will be paid May 6, 2022 with an ex-dividend date of Apr 27, 2022. | Neutral | |
| 2021-09-08 06:07 EST | Dividend | A dividend of $0.32 has been announced on Aug 23, 2021. It will be paid Sep 15, 2021 with an ex-dividend date of Sep 8, 2021. | Neutral | |
| 2021-08-24 15:17 EST | News | China Medical System Holdings Limited reports 1H results | N/A | |
| 2021-04-30 06:09 EST | Dividend | A dividend of $0.24 has been announced on Mar 16, 2021. It will be paid May 10, 2021 with an ex-dividend date of Apr 30, 2021. | Neutral | |
| 2020-12-04 18:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-30 06:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-27 06:04 EST | Dividend | A dividend of $0.23 has been announced on Aug 12, 2020. It will be paid Sep 4, 2020 with an ex-dividend date of Aug 27, 2020. | Neutral | |
| 2020-08-14 11:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 06:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-09 06:06 EST | Dividend | A dividend of $0.21 has been announced on Mar 31, 2020. It will be paid Jun 17, 2020 with an ex-dividend date of Jun 9, 2020. | Neutral | |
| 2020-05-27 08:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-14 18:15 EST | News | CytoSorbents up 6% premarket on CytoSorb deal in Asia | N/A | |
| 2020-04-09 23:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 23:04 EST | Financials | Company financials have been released. | Neutral | |
About China Medical System Holdings Limited (CHSYF):
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products to hospital and medical institutions in the People's Republic of China. It offers products under the direct and agency networks. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for the treatment of blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise Tanshinone capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu, for treating respiratory diseases; Ganfule capsules for the treatment of primary carcinoma of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for bone pains; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. It also engages in the agriculture business. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
General
- Name China Medical System Holdings Limited
- Symbol CHSYF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 4,147
- Fiscal Year EndDecember
- Web URLhttp://www.cms.net.cn
Financials
- Most Recent Quarter 2020-06-30
- Profit Margin 36%
- Return on Assets 15%
- Return on Equity 25%
- Revenue Per Share $0
- Gross Profit 5.13 billion
- Quarterly Earnings Growth 23.4%
Highlights
- Market Capitalization 5.84 billion
Share Statistics
- Shares Outstanding 2.49 billion
- Shares Float 1.26 billion
- % Held by Insiders 4918%
- % Held by Institutions 23.11%
Technicals
- Beta 0.44
- 52 Week High $1.26
- 52 Week Low $1.01
- 50 Day Moving Average 1.01
- 200 Day Moving Average 1.1
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
China Medical System Holdings Limited (CHSYF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
China Medical System Holdings Limited (CHSYF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-06-30 | $N/A | $0.04 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $N/A | $0.04 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $N/A | $0.02 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $1.48 billion | $0.02 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $1.48 billion | $0.03 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $1.39 billion | $0.04 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $1.39 billion | $0.03 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $1.33 billion | $0.03 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $1.33 billion | $0.03 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $1.33 billion | $0.03 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $1.33 billion | $0.03 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $1.34 billion | $0.03 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $1.34 billion | $0.02 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $0.02 | $0.00 | ||
| 2016-09-30 | 2016-12-31 | $0.02 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $0.02 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.02 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.02 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.02 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.02 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.02 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.02 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.02 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.02 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.01 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.01 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.01 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.01 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.01 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.01 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.01 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.01 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.01 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.01 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.01 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.01 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.01 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.01 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.00 | $0.00 |
China Medical System Holdings Limited (CHSYF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | 649.28 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 496.65 million |
| Gross Profit | N/A | N/A | N/A | N/A | 1.11 billion |
| Ebit | N/A | N/A | N/A | N/A | 612.09 million |
| Operating Income | N/A | N/A | N/A | N/A | 612.09 million |
| Income Tax Expense | 83.44 million | 83.44 million | 200.49 million | 200.49 million | 65.52 million |
| Total Revenue | N/A | N/A | N/A | N/A | 1.48 billion |
| Cost of Revenue | N/A | N/A | N/A | N/A | 373.44 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 37.19 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 583.76 million |
| Net Income Applicable to Common Shares | 639.71 million | 639.71 million | 395.41 million | 395.41 million | 584.95 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | -17.35 million |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -127.97 million | -127.97 million | -97.69 million | -97.69 million | -57.01 million |
| Net Borrowings | -9.8 million | -9.8 million | 18.64 million | 18.64 million | -18.64 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -212.97 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | 411.68 million |
| Total Cash from Operating Activities | 719.51 million | 719.51 million | 595.96 million | 595.96 million | 681.6 million |
| Depreciation | N/A | N/A | N/A | N/A | 49.23 million |
| Other Cash Flow from Investing Activities | 48.08 million | 48.08 million | -185.44 million | -185.44 million | 30.74 million |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -9.6 million | -9.6 million | -653.24 million | -653.24 million | -16.49 million |
| Change to Net Income | 29.91 million | 29.91 million | 249.78 million | 249.78 million | 47.42 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | 18.84 million |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 2.08 billion |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | 9.17 billion |
| Other Current Liabilities | N/A | N/A | N/A | N/A | 225.56 million |
| Total Assets | N/A | N/A | N/A | N/A | 11.3 billion |
| Common Stock | 84.63 million | 84.63 million | 84.96 million | 84.96 million | 84.96 million |
| Other Current Assets | N/A | N/A | N/A | N/A | 83.35 million |
| Retained Earnings | N/A | N/A | N/A | N/A | 6.67 billion |
| Other Liabilities | 101.24 million | 101.24 million | 96.65 million | 96.65 million | 95.73 million |
| Other Assets | 591.7 million | 591.7 million | 377.24 million | 377.24 million | 175.59 million |
| Cash | N/A | N/A | N/A | N/A | 1.64 billion |
| Total Current Liabilities | N/A | N/A | N/A | N/A | 1.98 billion |
| Other Stockholder Equity | 10.25 billion | 10.25 billion | 9.39 billion | 9.39 billion | 27.92 million |
| Property, Plant & Equipment | 535.26 million | 535.26 million | 537.89 million | 537.89 million | 543.21 million |
| Total Current Assets | N/A | N/A | N/A | N/A | 3.84 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 2.82 billion |
| Net Tangible Assets | 6.57 billion | 6.57 billion | 5.63 billion | 5.63 billion | 5.24 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | 429.81 million |
| Accounts Payable | N/A | N/A | N/A | N/A | 112.11 million |
China Medical System Holdings Limited (CHSYF) Chart:
China Medical System Holdings Limited (CHSYF) News:
Below you will find a list of latest news for China Medical System Holdings Limited (CHSYF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
China Medical System Holdings Limited (CHSYF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
China Medical System Holdings Limited (CHSYF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|